CaterinaPMinnitiMD

Pediatric Hematology & Oncology • Bronx, NY

Physician

Join to view full profile

Dr. Minniti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Minniti's full profile

Already have an account?

Office
1695 Eastchester Rd
Ste L2
Bronx, NY 10461
Phone+1 718-405-8505

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1988 - 1992
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1987 - 1988
University of MarylandResidency, Pediatrics, 1985 - 1987
Univ Catania- Fac MedClass of 1982

Certifications & Licensure

NY State Medical License 2015 - 2025
MD State Medical License 1986 - 2017
DC State Medical License 1992 - 2014
VA State Medical License 2000 - 2008
LA State Medical License 1996 - 1998

Clinical Trials

Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers Start of enrollment: 2018 Apr 06
Completed
Phase 2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Concentration of voxelotor in sickle cell disease can be estimated using electrophoresis and high-performance liquid chromatography.
Susanna A Curtis, Elana Friedman, Caterina Minniti, Annie Nguyen Dang, Mira Pochron
American Journal of Clinical Pathology. 2024-09-03
Let's get "real" in sickle cell disease: Real-world data and long-term patients' registries.
Caterina P Minniti
American Journal of Hematology. 2024-06-01
2 citations
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.
Mark T Gladwin, Victor R Gordeuk, Payal C Desai, Caterina Minniti, Enrico M Novelli
The Lancet. Haematology. 2024-05-01

Press Mentions

Older Age, Pre-Existing Comorbidities Increase Poor Outcomes in Patients with SCD and COVID-19March 1st, 2021
Sickle Cell Disease Brings Higher Risk of Coronavirus Death, but Inconsistent TreatmentJuly 15th, 2020